In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
Rao
Shilpakala Sainath
SS
Raghunathan
Raghavachari
R
Ekambaram
Ramesh
R
Raghunathan
Malathi
M
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D019535:Mycoplasma hominis / Q000187:drug effects*; D009177:Mycoplasma pneumoniae / Q000187:drug effects*; D011019:Pneumonia, Mycoplasma / Q000382:microbiology*; D011804:Quinolines / Q000737:chemistry / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D011804:Quinolines; C037219:quinoline